Drug intelligence / Profile preview

Niaosuanning

Development stage: Unknown
Lead developer: First Affiliated Hospital of Guangzhou University of Chinese Medicine
Administration: Oral

Overview

Niaosuanning is a Traditional Chinese Medicine (TCM) formulation, specifically known as "Jianpi Yishen Huazhuo". It is being investigated for the treatment of hyperuricemia. The drug is administered orally, either as granules dissolved in boiled water or as a traditional Chinese medicine decoction. Clinical trials are evaluating its efficacy compared to Western medicine for this condition.

Other names: Niaosuanning GranulesNiaosuanning (Jianpi Yishen Huazhuo) GranulesNiaosuanning (Jianpi Yishen Huazhuo) traditional Chinese medicine decoction

Beyond the preview

Go deeper on Niaosuanning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niaosuanning.

Explore the full profile